生物膜
抗菌剂
铜绿假单胞菌
微生物学
金黄色葡萄球菌
抗菌肽
抗生素
医学
细菌
生物
遗传学
作者
Danir F Bayramov,Zhenghao Li,Esha Patel,Mina J. Izadjoo,Hosan Kim,J. A. Neff
出处
期刊:Military Medicine
[Oxford University Press]
日期:2018-03-01
卷期号:183 (suppl_1): 481-486
被引量:13
标识
DOI:10.1093/milmed/usx135
摘要
Wound infections are a common complication of combat-related injuries that significantly increase morbidity and mortality. Multi-drug resistant (MDR) organisms and their associated biofilms play a significant role in the pathogenicity and chronicity of wound infections. A critical barrier to progress in the treatment of traumatic wounds is the need for broad spectrum antimicrobials that are effective against biofilms and compatible with topical delivery. In this study, we present the in vitro efficacy of two de novo designed cationic, antimicrobial peptides and related topical formulations against single species and polymicrobial biofilms of MDR bacteria. Minimum biofilm eradication concentrations for peptides ranged from 0.7 μM for Staphylococcus aureus to 13.2 μM for Pseudomonas aeruginosa. Varying pH did not adversely impact peptide activity, however, in the presence of albumin, minimum biofilm eradication concentrations generally increased. When formulated into gels or dressings, both peptides eradicated mono- and polymicrobial biofilms of MDR pathogens. The biocompatibility index (BI) was found to be greater than one for both ASP-1 and ASP-2, with a slightly greater (more favorable) BI for ASP-2. The BIs for both peptides were greater than BIs previously reported for commonly used topical antimicrobial agents. The antimicrobial peptides and related formulations presented provide a promising platform for treatment of wound biofilms to improve outcomes for those injured in combat.
科研通智能强力驱动
Strongly Powered by AbleSci AI